1. Home
  2. WAY vs HAE Comparison

WAY vs HAE Comparison

Compare WAY & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Waystar Holding Corp.

WAY

Waystar Holding Corp.

HOLD

Current Price

$24.67

Market Cap

3.8B

Sector

N/A

ML Signal

HOLD

Logo Haemonetics Corporation

HAE

Haemonetics Corporation

HOLD

Current Price

$86.82

Market Cap

3.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WAY
HAE
Founded
1999
1971
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.8B
3.8B
IPO Year
2023
1996

Fundamental Metrics

Financial Performance
Metric
WAY
HAE
Price
$24.67
$86.82
Analyst Decision
Strong Buy
Buy
Analyst Count
17
9
Target Price
$36.59
$84.13
AVG Volume (30 Days)
2.9M
720.7K
Earning Date
04-29-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
569.23
N/A
EPS
0.43
0.72
Revenue
$1,099,278,000.00
$910,373,000.00
Revenue This Year
$18.26
N/A
Revenue Next Year
$10.62
$5.23
P/E Ratio
$56.35
$122.00
Revenue Growth
16.50
N/A
52 Week Low
$17.26
$47.32
52 Week High
$39.99
$88.59

Technical Indicators

Market Signals
Indicator
WAY
HAE
Relative Strength Index (RSI) 60.21 65.96
Support Level $23.79 $78.87
Resistance Level $24.67 $87.34
Average True Range (ATR) 1.06 2.85
MACD 0.13 0.26
Stochastic Oscillator 87.70 85.19

Price Performance

Historical Comparison
WAY
HAE

About WAY Waystar Holding Corp.

Waystar Holding Corp is a provider of mission-critical cloud technology to healthcare organizations. Its enterprise-grade platform transforms the complex and disparate processes comprising healthcare payments received by healthcare providers from payers and patients, from pre-service engagement through post-service remittance and reconciliation. its platform enhances data integrity, eliminates manual tasks, and improves claim and billing accuracy, which results in transparency, reduced labor costs, and faster, more accurate reimbursement and cash flow. The market for solutions extends throughout the United States and includes Puerto Rico and other USA Territories.

About HAE Haemonetics Corporation

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.

Share on Social Networks: